CSIMarket Company Name, Ticker, Industry, else..
 
Peak Bio Inc   (NONE: PKBO)
 

PKBO's Market share relative to its competitors, as of Q3 2024

As of Q3 2024 (Revenue in Millions of $)

Date modified: 2026-08-28T06:27:08+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2024		 MARKET SHARE
12 Months
Q3 2024		 MARKET SHARE
MRQ
Q3 2024		 MARKET SHARE
A Quarter Before
Q2 2024
Peak Bio Inc 0.00 0.00% 0.00 % 0.00 %
Astrazeneca Plc 58,739.00 32.47% 32.47% 65.94%
Amgen Inc 38,095.00 21.06% 21.70% 10.51%
Gilead Sciences Inc 30,457.00 16.84% 16.84% 8.49%
Regeneron Pharmaceuticals Inc 15,534.70 8.59% 9.26% 4.40%
Vertex Pharmaceuticals Inc 12,587.20 6.96% 7.20% 3.64%
65 more competitors available

Sign in to see all competitors for Peak Bio Inc .

Sign In Create Free Account



PKBO's Market share relative to its competitors, as of Q3 2024 within the Biotechnology & Pharmaceuticals Industry
As of Q3 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
12 Months Ending
Q2 2024		 MARKET SHARE
MRQ
Q3 2024		 MARKET SHARE

Q2 2024
Peak Bio Inc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 40.51% 38.17% 41.85% 40.39%
Gilead Sciences Inc 32.39% 33.63% 32.48% 32.62%
Biogen Inc 10.57% 11.30% 10.31% 10.68%
Biontech Se 3.42% 3.52% 3.42% 3.52%
Exelixis Inc 2.59% 2.65% 2.62% 2.86%
62 more companies available

Sign in to see all industry competitors for Peak Bio Inc .

Sign In Create Free Account



PKBO's Market share relative to its competitors, as of Q3 2024 within the Healthcare Sector
As of Q3 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
12 Months Ending
Q2 2024		 MARKET SHARE
MRQ
Q3 2024		 MARKET SHARE

Q2 2024
Peak Bio Inc 0.00% 0.00% 0.00 % 0.00 %
Astrazeneca Plc 32.47% 28.68% 32.47% 65.94%
Amgen Inc 21.06% 20.93% 21.70% 10.51%
Gilead Sciences Inc 16.84% 18.44% 16.84% 8.49%
Regeneron Pharmaceuticals Inc 8.59% 8.98% 9.26% 4.40%
Vertex Pharmaceuticals Inc 6.96% 7.51% 7.20% 3.64%
65 more companies available

Sign in to see all sector competitors for Peak Bio Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Peak Bio Inc's market divisions, geographic dispersion, segments, products, and services, visit Peak Bio Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.